Matinas BioPharma Holdings (MTNB) Capital Expenditures (QoQ) (2013 - 2022)
Matinas BioPharma Holdings (MTNB) Capital Expenditures (QoQ) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -83.20% |
| Sep 30, 2022 | 354.55% |
| Jun 30, 2022 | -89.91% |
| Mar 31, 2022 | 1,421.84% |
| Sep 30, 2019 | -76.90% |
| Jun 30, 2019 | 2,131.70% |
| Sep 30, 2018 | 73.49% |
| Jun 30, 2018 | 55.71% |
| Mar 31, 2018 | -13.85% |
| Dec 31, 2017 | 246.08% |
| Dec 31, 2015 | 58.01% |
| Sep 30, 2015 | -57.17% |
| Jun 30, 2015 | 599.46% |
| Mar 31, 2015 | 102.73% |
| Dec 31, 2014 | -200.00% |
| Sep 30, 2014 | 315.89% |
| Jun 30, 2014 | -142.52% |
| Mar 31, 2014 | 193.33% |
| Dec 31, 2013 | 132.84% |